X, an internet-based generative AI tool that enables scientists to design protein binders with no coding required. The ...

The PLI Scheme for Bulk Drugs has a total budgetary outlay of Rs 6,940 crore and aims to avoid disruption in supply of ...

Replimune stock (ticker: REPL) cratered on Tuesday after the biotech said the U.S. Food and Drug Administration rejected an ...

The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.

With ₹700 crore in budgetary support, seven CoEs have been established at the National Institutes of Pharmaceutical Education ...

The Danaher Business System focuses on continuous improvement, including the acceleration of core growth and margin expansion through marketing initiatives and innovation, which appears positive for ...

West Pharmaceutical Services Inc. (NYSE:WST) is one of the most oversold S&P 500 stocks so far in 2025. On June 24, Barclays ...

With certain drug shortages persisting across the U.S., pharmacy leaders are adopting more coordinated strategies to manage supply disruptions. These include expanding on-hand inventory for critical ...

The deal sees Ampersand Capital Partners acquire the company that has manufacturing locations in both South Carolina and the ...

Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...